Show simple item record

Characteristics of Turkish colorectal cancer patients and bevacizumab preference.

dc.contributor.authorOzyilkan, Ozgur
dc.contributor.authorUslu, Ruchan
dc.contributor.authorKara, Oguz
dc.contributor.authorGuducu, Merve
dc.contributor.authorErdogan, Alper
dc.contributor.authorCicin, Irfan
dc.contributor.authorGumus, Mahmut
dc.contributor.authorUncu, Dogan
dc.contributor.authorOzkan, Metin
dc.contributor.authorKilickap, Saadettin
dc.contributor.authorElkiran, Tamer E.
dc.contributor.authorIsikdogan, Abdurrahman
dc.contributor.authorKaraoglu, Aziz
dc.contributor.authorOksuzoglu, Berna
dc.contributor.authorOzdemir, Feyyaz
dc.contributor.authorTurna, Hande
dc.date.accessioned2021-03-03T11:51:23Z
dc.date.available2021-03-03T11:51:23Z
dc.identifier.citationCicin I., Gumus M., Uncu D., Ozkan M., Kilickap S., Elkiran T. E. , Isikdogan A., Karaoglu A., Oksuzoglu B., Ozdemir F., et al., "Characteristics of Turkish colorectal cancer patients and bevacizumab preference.", 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35
dc.identifier.othervv_1032021
dc.identifier.otherav_2a5a20e0-0547-489f-b025-d6e91e948c1d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/33261
dc.identifier.urihttps://doi.org/10.1200/jco.2017.35.15_suppl.e15055
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleCharacteristics of Turkish colorectal cancer patients and bevacizumab preference.
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume35
dc.contributor.firstauthorID151461


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record